{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:03:21Z","timestamp":1794434601827,"version":"4.9.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["JQ24039"],"award-info":[{"award-number":["JQ24039"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L2510069"],"award-info":[{"award-number":["L2510069"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2022YFC2505600"],"award-info":[{"award-number":["2022YFC2505600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2025ZD0548201"],"award-info":[{"award-number":["2025ZD0548201"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0529100"],"award-info":[{"award-number":["2024ZD0529100"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2024-I2M-3-020"],"award-info":[{"award-number":["2024-I2M-3-020"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470339"],"award-info":[{"award-number":["82470339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Study Objectives<\/jats:title>\n                    <jats:p>The impact of obstructive sleep apnea (OSA) on subsequent cardiovascular events in patients with acute coronary syndrome (ACS) remains debated. This study aims to investigate whether the association of OSA with cardiovascular events is affected by lipoprotein (a) [Lp(a)] levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a sub-analysis of prospective cohort study (OSA-ACS, NCT03362385) enrolled ACS patients. OSA defined as an apnea-hypopnea index \u226515 events\/h. The effects of OSA on subsequent cardiovascular outcomes were evaluated across varying Lp(a) thresholds. Coronary plaque features by coronary computed tomography angiography were also analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1137 patients were enrolled, 608 patients (53.5%) were diagnosed with OSA. At a median follow-up of 3.6 years, OSA was associated with a higher risk of major adverse cardiovascular and cerebrovascular events (MACCE) in patients with Lp(a) level &amp;gt;median (HR 1.59, 95% CI 1.12-2.26, P=0.009), but not in patients with Lp(a) level \u2264median (HR 1.09, 95% CI 0.80-1.49, P=0.60). There were consistent increases in HRs for MACCE in the OSA group with Lp(a) levels rising, as stratified by tertiles or quartiles of Lp(a). In patients with Lp(a) level &amp;gt;median, OSA demonstrated a higher prevalence of \u22651 high-risk plaque (HRP) feature (51.4% vs. 33.3%, P=0.03) and low-attenuation plaque (50.0% vs. 32.8, P=0.04) per vessel than non-OSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>OSA was associated with a continuously increased cardiovascular risk and a higher prevalence of HRP features as Lp(a) levels rose. Lp(a) may help identify ACS patients at higher cardiovascular risk, in whom the efficacy of OSA treatment should be further investigated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/sleep\/zsag062","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:23:44Z","timestamp":1772454224000},"source":"Crossref","is-referenced-by-count":1,"title":["Obstructive sleep apnea, lipoprotein(a) and long-term cardiovascular outcomes in acute coronary syndrome"],"prefix":"10.1093","volume":"49","author":[{"given":"Wen","family":"Hao","sequence":"first","affiliation":[{"name":"Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, National Clinical Research Center for Cardiovascular Diseases, Capital Medical University , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Qiu","sequence":"additional","affiliation":[{"name":"Education Department, Beijing Chaoyang Hospital, Capital Medical University , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, National Clinical Research Center for Cardiovascular Diseases, Capital Medical University , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital) , Qingdao ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, National Clinical Research Center for Cardiovascular Diseases, Capital Medical University , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8549-3398","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8499-0448","authenticated-orcid":false,"given":"Lei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoping","family":"Nie","sequence":"additional","affiliation":[{"name":"Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, National Clinical Research Center for Cardiovascular Diseases, Capital Medical University , Beijing ,","place":["China"]},{"name":"International Hospital, Peking University , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"14","key":"2026061506422153000_ref1","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1001\/jama.2020.3514","article-title":"Diagnosis and management of obstructive sleep apnea: a review","volume":"323","author":"Gottlieb","year":"2020","journal-title":"JAMA."},{"issue":"8","key":"2026061506422153000_ref2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"5","key":"2026061506422153000_ref3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.hlc.2016.09.010","article-title":"Effects of ethnicity on the prevalence of obstructive sleep apnoea in patients with acute coronary syndrome: a pooled analysis of the ISAACC trial and sleep and stent study","volume":"26","author":"Koo","year":"2017","journal-title":"Heart Lung Circ"},{"issue":"2","key":"2026061506422153000_ref4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4093\/dmj.2018.0256","article-title":"Metabolic consequences of obstructive sleep apnea especially pertaining to diabetes mellitus and insulin sensitivity","volume":"43","author":"Song","year":"2019","journal-title":"Diabetes Metab J"},{"issue":"3","key":"2026061506422153000_ref5","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000988","article-title":"Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association","volume":"144","author":"Yeghiazarians","year":"2021","journal-title":"Circulation."},{"issue":"5","key":"2026061506422153000_ref6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1164\/rccm.201601-0088OC","article-title":"Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial","volume":"194","author":"Peker","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"2026061506422153000_ref7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1606599","article-title":"CPAP for prevention of cardiovascular events in obstructive sleep apnea","volume":"375","author":"McEvoy","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"2026061506422153000_ref8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S2213-2600(19)30271-1","article-title":"Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial","volume":"8","author":"Sanchez-de-la-Torre","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"7","key":"2026061506422153000_ref9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/thorax-2023-220037","article-title":"Endotyping, phenotyping and personalised therapy in obstructive sleep apnoea: are we there yet?","volume":"78","author":"Turnbull","year":"2023","journal-title":"Thorax."},{"issue":"13","key":"2026061506422153000_ref10","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.jacc.2024.07.024","article-title":"Treatment of OSA and its impact on cardiovascular disease, part 2: JACC state-of-the-art review","volume":"84","author":"Javaheri","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2026061506422153000_ref11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"NHLBI working group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis","volume":"71","author":"Tsimikas","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2026061506422153000_ref12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jacc.2021.04.102","article-title":"Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol","volume":"78","author":"Schwartz","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2026061506422153000_ref13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jacc.2023.10.039","article-title":"Lipoprotein(a) is markedly more atherogenic than LDL: an apolipoprotein B-based genetic analysis","volume":"83","author":"Bjornson","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2026061506422153000_ref14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01110-2022","article-title":"Association of obstructive sleep apnoea with cardiovascular events in women and men with acute coronary syndrome","volume":"61","author":"Wang","year":"2023","journal-title":"Eur Respir J"},{"issue":"1","key":"2026061506422153000_ref15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chest.2023.02.001","article-title":"Prognostic implications of OSA in acute coronary syndrome by obesity status","volume":"164","author":"Hao","year":"2023","journal-title":"Chest."},{"issue":"7","key":"2026061506422153000_ref16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.amjcard.2015.12.053","article-title":"Effect of obstructive sleep apnea in acute coronary syndrome","volume":"117","author":"Leao","year":"2016","journal-title":"Am J Cardiol"},{"issue":"5","key":"2026061506422153000_ref17","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition: highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest."},{"issue":"6","key":"2026061506422153000_ref18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jcct.2016.10.002","article-title":"SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee: endorsed by the North American Society for Cardiovascular Imaging (NASCI)","volume":"10","author":"Abbara","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"5","key":"2026061506422153000_ref19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jcct.2014.07.003","article-title":"SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee","volume":"8","author":"Leipsic","year":"2014","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"8","key":"2026061506422153000_ref20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"2026061506422153000_ref21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jacc.2021.10.044","article-title":"Association of lipoprotein(a) with atherosclerotic plaque progression","volume":"79","author":"Kaiser","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"39","key":"2026061506422153000_ref22","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"issue":"4","key":"2026061506422153000_ref23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5664\/jcsm.8242","article-title":"Association between obstructive sleep apnea and lipid metabolism during REM and NREM sleep","volume":"16","author":"Xu","year":"2020","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"2026061506422153000_ref24","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s11325-021-02290-7","article-title":"Obstructive sleep apnea is associated with lower adiponectin and higher cholesterol levels independently of traditional factors and other sleep disorders in middle-aged adults: the ELSA-Brasil cohort","volume":"25","author":"Silva","year":"2021","journal-title":"Sleep Breath"},{"issue":"12","key":"2026061506422153000_ref25","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1513\/AnnalsATS.202306-547RL","article-title":"Does obstructive sleep apnea treatment influence lipoprotein (a) concentrations? Data from the TREATOSA-MS clinical trial","volume":"20","author":"Giampa","year":"2023","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"2026061506422153000_ref26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.chest.2016.03.002","article-title":"Effect of continuous positive airway pressure on cardiovascular biomarkers: the sleep apnea stress randomized controlled trial","volume":"150","author":"Paz","year":"2016","journal-title":"Chest."},{"key":"2026061506422153000_ref27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.069556","article-title":"Independence of lipoprotein(a) and low-density lipoprotein cholesterol-mediated cardiovascular risk: a participant-level meta-analysis","author":"Bhatia","year":"2025","journal-title":"Circulation."},{"issue":"21","key":"2026061506422153000_ref28","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.jacc.2025.04.010","article-title":"Global variation in lipoprotein(a) levels among patients with coronary heart disease: insights from the INTERASPIRE study and implications for emerging Lp(a)-lowering therapies","volume":"85","author":"Barkas","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2026061506422153000_ref29","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jamacardio.2024.1874","article-title":"Lipoprotein(a) and long-term plaque progression, low-density plaque, and pericoronary inflammation","volume":"9","author":"Nurmohamed","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"12","key":"2026061506422153000_ref30","doi-asserted-by":"publisher","first-page":"e014611","DOI":"10.1161\/CIRCIMAGING.122.014611","article-title":"Association of lipoprotein (a) with coronary-computed tomography angiography-assessed high-risk coronary disease attributes and cardiovascular outcomes","volume":"15","author":"Dai","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026061506422153000_ref31","doi-asserted-by":"publisher","first-page":"9583286","DOI":"10.1155\/2019\/9583286","article-title":"Effect of the interaction between obstructive sleep apnea and lipoprotein(a) on insulin resistance: a large-scale cross-sectional study","volume":"2019","author":"Liu","year":"2019","journal-title":"J Diabetes Res"},{"issue":"5","key":"2026061506422153000_ref32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.5665\/sleep.4678","article-title":"Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance","volume":"38","author":"Liu","year":"2015","journal-title":"Sleep."},{"issue":"12","key":"2026061506422153000_ref33","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/eurheartj\/ehae045","article-title":"Lipoprotein(a) association with residual risk: what has inflammation got to do with it?","volume":"45","author":"Farukhi","year":"2024","journal-title":"Eur Heart J"},{"issue":"5","key":"2026061506422153000_ref34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jacc.2021.04.103","article-title":"The residual risk odyssey: from LDL to Lp(a)","volume":"78","author":"Rosenson","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"2026061506422153000_ref35","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/eurheartj\/ehx033","article-title":"Lipoprotein(a): the revenant","volume":"38","author":"Gencer","year":"2017","journal-title":"Eur Heart J"}],"container-title":["SLEEP"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sleep\/advance-article-pdf\/doi\/10.1093\/sleep\/zsag062\/67249005\/zsag062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/49\/6\/zsag062\/67249005\/zsag062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/49\/6\/zsag062\/67249005\/zsag062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:42:30Z","timestamp":1781520150000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsag062\/8507955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3,6]]},"published-print":{"date-parts":[[2026,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsag062","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"value":"0161-8105","type":"print"},{"value":"1550-9109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,3,6]]},"article-number":"zsag062"}}